
About Extraxa Pharma Private Limited
Data last updated:
Extraxa Pharma Private Limited was a private limited company based in Mumbai, Maharashtra, India, operated as a subsidiary of Inventys Research Company Private Limited. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 14 April 2012.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2012PTC229677.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Deepak Baburao Birewar and Neeta Ajit Naik.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at D – 514 Kanakia Zillion BKC Annex Lbs Road Junction Cst Road Near Kurla Bus Depot, Mumbai, Maharashtra, India – 400070.
The last known website on record is inventys.in.
Company details
Contact details
Extraxa Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is inventys.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressD – 514 Kanakia Zillion BKC Annex Lbs Road Junction Cst Road Near Kurla Bus Depot, Mumbai, Maharashtra, India – 400070
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Extraxa Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Extraxa Pharma Private Limited
FY 2023 filings availableExtraxa Pharma Private Limited reported revenue of ₹955 (down 100% YoY) for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹955 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Extraxa Pharma Private Limited, buy the company report.
Board of directors of Extraxa Pharma Private Limited
Extraxa Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Baburao Birewar Also directs: Econets Private Limited, Inventys Research Company Private Limited | Director | 14 Apr 2012 | 14 Years 7 Months | As last reported |
| Neeta Ajit Naik Also directs: Econets Private Limited, En1 Neuro Services Private Limited | Director | 14 Apr 2012 | 14 Years 7 Months | As last reported |
| Shobana Birewar Also directs: Econets Private Limited | Director | 14 Apr 2012 | 14 Years 7 Months | As last reported |
Auditor
Extraxa Pharma Private Limited is audited by VINAY BHUSHAN & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VINAY BHUSHAN & ASSOCIATES | FY 2023 | 130529W |
Shareholding
The shareholding of Extraxa Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Extraxa Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Extraxa Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Extraxa Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Extraxa Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Extraxa Pharma Private Limited has 3 board changes on record since 2012: 3 appointments. The latest: Deepak Baburao Birewar was appointed as Director on 14 Apr 2012.
Frequently asked questions
Extraxa Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Extraxa Pharma was a private limited company based in Mumbai, Maharashtra, India. The company worked in ayurvedic products and services, within the healthcare industry. It was incorporated on 14 April 2012 and is registered under CIN U74120MH2012PTC229677. The company has been struck off by the Registrar of Companies and is no longer operational.
Extraxa Pharma had 3 directors:
- Deepak Baburao Birewar - Director
- Neeta Ajit Naik - Director
- Shobana Birewar - Director
The CIN (Corporate Identification Number) of Extraxa Pharma is U74120MH2012PTC229677. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Extraxa Pharma is at D – 514 Kanakia Zillion BKC Annex Lbs Road Junction Cst Road Near Kurla Bus Depot, Mumbai, Maharashtra, India – 400070.
Extraxa Pharma was incorporated on 14 April 2012. It is registered with the Registrar of Companies, Mumbai.
Extraxa Pharma can be reached through the website inventys.in. Its registered office is in Mumbai, Maharashtra, India.
The latest financial statements of Extraxa Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
Extraxa Pharma operated in the healthcare industry, in the ayurvedic products and services segment. It worked in this industry before it was struck off.
Deepak Baburao Birewar was appointed as Director on 14 Apr 2012. Neeta Ajit Naik was appointed as Director on 14 Apr 2012. Shobana Birewar was appointed as Director on 14 Apr 2012.

